hATTR amyloidosis genetic testing If tests find amyloid, genetic testing will help figure out whether you have hereditary ATTR amyloidosis (hATTR) or non-hereditary, which is commonly called wild ...

Neuroscientists have produced the largest wiring diagram and functional map of a mammalian brain to date using tissue from a part of a mouse's cerebral cortex involved in vision, an achievement ...

Wainua is an injectable medicine. Here’s how it treats hereditary transthyretin-mediated amyloidosis (hATTR).

Neuroscientists have reconstructed the first complete wiring map of the fruit-fly brain, including 140,000 neurons and more than 50 million connections. This resource has already begun to ...

Learn about uses, side effects, dosage, and more for Wainua. It's a prescription drug used to treat nerve problems in adults with a certain genetic condition.

The road trip trope is alive and well in medical marketing, as Alnylam Pharmaceuticals recently utilized the motif to raise awareness of hereditary ATTR (hATTR) amyloidosis. Last week, the ...

Currently, according to the American Heart Association, people with hATTR amyloidosis typically have a life expectancy of between 2.5 and 5 years after they’re diagnosed.

hATTR amyloidosis is a rapidly progressive disease caused by an inherited variant, or change, in the transthyretin (TTR) gene, which causes the TTR protein to take on an abnormal shape, misfold and ...

A misleading graphic circulating on social media understates man-made contributions to carbon dioxide (CO2) levels in the Earth’s atmosphere, overstates “natural” levels and downplays the ...

The only FDA-approved treatment for hATTR cardiomyopathy is Pfizer’s Vyndaqel, a small molecule designed to stabilize the transthyretin protein.

New study published in the BMJ Open calls for major shift in the management of hATTR amyloidosis Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced ...